A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia.

Trial Profile

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia.

Phase of Trial: Phase II/III

Latest Information Update: 28 Feb 2018

At a glance

  • Drugs Brexpiprazole (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical
  • Most Recent Events

    • 28 Feb 2018 Meta-analysis of this study has been reported in UMIN-CTR clinical trial(UMIN000031422' reciept number: R000035871) assessing drug response in Japanese patients with schizophrenia based on information in clinical evaluation index and genetic information collected from those patients who have attended this clinical trial.
    • 05 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 15 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top